The evaluation of microbiome in liver abscess patients
- Conditions
- Diseases of the digestive system
- Registration Number
- KCT0003857
- Lead Sponsor
- Catholic Kwandong University International St.Mary's Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 100
1) Adult men and women over 20 years of age
2) A person who has signed a written agreement with a description of the purpose and method of clinical research
3) Patients requiring liver abscess drainage or fine-needle aspiration
4) Those who have participated in other clinical studies within 60 days before enrollment in this clinical study
5) A person who is judged to be inadequate in participating in clinical research
<control group>
1) Adult men and women over 20 years of age
2) A person who has signed a written agreement with a description of the purpose and method of clinical research
3) A person whose alcohol intake is 30g or less for men or 20g or less for women.
4) Normal people without history of hypertension, diabetes and chronic hepatitis.
5) Without liver abscess and bacterial inflammatory disease (eg, pneumonia, pyelonephritis, abscess,
1) Patients who received antibiotics for the treatment of symptoms associated with liver abscess before participating in the clinical study
2) women who are pregnant or lactating, whose pregnancies have been confirmed by means of pregnancy tests of serum or urine specimens, or who are planning a pregnancy during the test period or who are pregnant but do not use approved methods of contraception
3) Persons with bacterial inflammatory disease other than liver abscess (eg, pneumonia, pyelonephritis, abscess, sepsis, etc.)
4) Those who have participated in other clinical studies within 60 days before enrollment in this clinical study
5) Others Judged by the tester as inappropriate for participation in clinical research
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Differences in distribution of intestinal microorganisms
- Secondary Outcome Measures
Name Time Method iver enzyme levels and inflammatory response in blood